Compile Data Set for Download or QSAR
Report error Found 62 Enz. Inhib. hit(s) with all data for entry = 1798
LigandPNGBDBM202376(US9238629, I-8 | US10081606, Compound I-8 | US9765...)
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

LigandPNGBDBM202371(US9238629, I-3 | US10081606, Compound I-3 | US9765...)
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

LigandPNGBDBM202379(US9238629, I-11 | US10081606, Compound I-11 | US97...)
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

LigandPNGBDBM202378(US9238629, I-10 | US10081606, Compound I-10 | US97...)
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

LigandPNGBDBM202373(US9238629, I-5 | US10081606, Compound I-5 | US9765...)
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

LigandPNGBDBM202380(US9238629, I-12 | US10081606, Compound I-12 | US97...)
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

LigandPNGBDBM202369(US9238629, I-1 | US10081606, Compound I-1 | US9765...)
Affinity DataIC50: 5.5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

LigandPNGBDBM202377(US9238629, I-9 | US10081606, Compound I-9 | US9765...)
Affinity DataIC50: 5.5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

LigandPNGBDBM202384(US9238629, I-16 | US10081606, Compound I-16 | US97...)
Affinity DataIC50: 5.5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

LigandPNGBDBM202370(US9238629, I-2 | US10081606, Compound I-2 | US9765...)
Affinity DataIC50: 5.5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

LigandPNGBDBM202381(US9238629, I-13 | US10081606, Compound I-13 | US97...)
Affinity DataIC50: 5.5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

LigandPNGBDBM202389(US9238629, I-21 | US10081606, Compound I-21 | US97...)
Affinity DataIC50: 5.5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

LigandPNGBDBM202388(US9238629, I-20 | US10081606, Compound I-20 | US97...)
Affinity DataIC50: 5.5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

LigandPNGBDBM202372(US9238629, I-4 | US10081606, Compound I-4 | US9765...)
Affinity DataIC50: 5.5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

LigandPNGBDBM202383(US9238629, I-15 | US10081606, Compound I-15 | US97...)
Affinity DataIC50: 5.5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

LigandPNGBDBM202375(US9238629, I-7 | US10081606, Compound I-7 | US9765...)
Affinity DataIC50: 5.5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

LigandPNGBDBM285865(US10081606, Compound I-14 | US9765038, Compound I-...)
Affinity DataIC50: 5.5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

LigandPNGBDBM202390(US9238629, I-22 | US10081606, Compound I-22 | US97...)
Affinity DataIC50: 5.5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Car

US Patent
LigandPNGBDBM202371(US9238629, I-3 | US10081606, Compound I-3 | US9765...)
Affinity DataIC50: 20nMAssay Description:The mechanics of the assay platform are best described by the vendor (Invitrogen, Carlsbad, Calif.) on their web site at the following URL: www.invit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Car

US Patent
LigandPNGBDBM202379(US9238629, I-11 | US10081606, Compound I-11 | US97...)
Affinity DataIC50: 20nMAssay Description:The mechanics of the assay platform are best described by the vendor (Invitrogen, Carlsbad, Calif.) on their web site at the following URL: www.invit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

LigandPNGBDBM202387(US9238629, I-19 | US10081606, Compound I-19 | US97...)
Affinity DataIC50: 20nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

LigandPNGBDBM202386(US9238629, I-18 | US10081606, Compound I-18 | US97...)
Affinity DataIC50: 20nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Car

US Patent
LigandPNGBDBM202375(US9238629, I-7 | US10081606, Compound I-7 | US9765...)
Affinity DataIC50: 20nMAssay Description:The mechanics of the assay platform are best described by the vendor (Invitrogen, Carlsbad, Calif.) on their web site at the following URL: www.invit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

LigandPNGBDBM202391(US9238629, I-23 | US10081606, Compound I-23 | US97...)
Affinity DataIC50: 20nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

LigandPNGBDBM202374(US9238629, I-14 | US9238629, I-6 | US10081606, Com...)
Affinity DataIC50: 20nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

LigandPNGBDBM285868(US10081606, Compound I-17 | US9765038, Compound I-...)
Affinity DataIC50: 55nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Car

US Patent
LigandPNGBDBM202376(US9238629, I-8 | US10081606, Compound I-8 | US9765...)
Affinity DataIC50: 65nMAssay Description:The mechanics of the assay platform are best described by the vendor (Invitrogen, Carlsbad, Calif.) on their web site at the following URL: www.invit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Car

US Patent
LigandPNGBDBM202378(US9238629, I-10 | US10081606, Compound I-10 | US97...)
Affinity DataIC50: 65nMAssay Description:The mechanics of the assay platform are best described by the vendor (Invitrogen, Carlsbad, Calif.) on their web site at the following URL: www.invit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Car

US Patent
LigandPNGBDBM202381(US9238629, I-13 | US10081606, Compound I-13 | US97...)
Affinity DataIC50: 65nMAssay Description:The mechanics of the assay platform are best described by the vendor (Invitrogen, Carlsbad, Calif.) on their web site at the following URL: www.invit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Car

US Patent
LigandPNGBDBM202373(US9238629, I-5 | US10081606, Compound I-5 | US9765...)
Affinity DataIC50: 65nMAssay Description:The mechanics of the assay platform are best described by the vendor (Invitrogen, Carlsbad, Calif.) on their web site at the following URL: www.invit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Car

US Patent
LigandPNGBDBM202388(US9238629, I-20 | US10081606, Compound I-20 | US97...)
Affinity DataIC50: 65nMAssay Description:The mechanics of the assay platform are best described by the vendor (Invitrogen, Carlsbad, Calif.) on their web site at the following URL: www.invit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Car

US Patent
LigandPNGBDBM202372(US9238629, I-4 | US10081606, Compound I-4 | US9765...)
Affinity DataIC50: 65nMAssay Description:The mechanics of the assay platform are best described by the vendor (Invitrogen, Carlsbad, Calif.) on their web site at the following URL: www.invit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Car

US Patent
LigandPNGBDBM202369(US9238629, I-1 | US10081606, Compound I-1 | US9765...)
Affinity DataIC50: 200nMAssay Description:The mechanics of the assay platform are best described by the vendor (Invitrogen, Carlsbad, Calif.) on their web site at the following URL: www.invit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Car

US Patent
LigandPNGBDBM202377(US9238629, I-9 | US10081606, Compound I-9 | US9765...)
Affinity DataIC50: 200nMAssay Description:The mechanics of the assay platform are best described by the vendor (Invitrogen, Carlsbad, Calif.) on their web site at the following URL: www.invit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Car

US Patent
LigandPNGBDBM202384(US9238629, I-16 | US10081606, Compound I-16 | US97...)
Affinity DataIC50: 200nMAssay Description:The mechanics of the assay platform are best described by the vendor (Invitrogen, Carlsbad, Calif.) on their web site at the following URL: www.invit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Car

US Patent
LigandPNGBDBM202387(US9238629, I-19 | US10081606, Compound I-19 | US97...)
Affinity DataIC50: 200nMAssay Description:The mechanics of the assay platform are best described by the vendor (Invitrogen, Carlsbad, Calif.) on their web site at the following URL: www.invit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Car

US Patent
LigandPNGBDBM202370(US9238629, I-2 | US10081606, Compound I-2 | US9765...)
Affinity DataIC50: 200nMAssay Description:The mechanics of the assay platform are best described by the vendor (Invitrogen, Carlsbad, Calif.) on their web site at the following URL: www.invit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Car

US Patent
LigandPNGBDBM202389(US9238629, I-21 | US10081606, Compound I-21 | US97...)
Affinity DataIC50: 200nMAssay Description:The mechanics of the assay platform are best described by the vendor (Invitrogen, Carlsbad, Calif.) on their web site at the following URL: www.invit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Car

US Patent
LigandPNGBDBM202383(US9238629, I-15 | US10081606, Compound I-15 | US97...)
Affinity DataIC50: 200nMAssay Description:The mechanics of the assay platform are best described by the vendor (Invitrogen, Carlsbad, Calif.) on their web site at the following URL: www.invit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Car

US Patent
LigandPNGBDBM202390(US9238629, I-22 | US10081606, Compound I-22 | US97...)
Affinity DataIC50: 200nMAssay Description:The mechanics of the assay platform are best described by the vendor (Invitrogen, Carlsbad, Calif.) on their web site at the following URL: www.invit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Car

US Patent
LigandPNGBDBM285868(US10081606, Compound I-17 | US9765038, Compound I-...)
Affinity DataIC50: 650nMAssay Description:The mechanics of the assay platform are best described by the vendor (Invitrogen, Carlsbad, Calif.) on their web site at the following URL: www.invit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Car

US Patent
LigandPNGBDBM202386(US9238629, I-18 | US10081606, Compound I-18 | US97...)
Affinity DataIC50: 650nMAssay Description:The mechanics of the assay platform are best described by the vendor (Invitrogen, Carlsbad, Calif.) on their web site at the following URL: www.invit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Car

US Patent
LigandPNGBDBM202380(US9238629, I-12 | US10081606, Compound I-12 | US97...)
Affinity DataIC50: 650nMAssay Description:The mechanics of the assay platform are best described by the vendor (Invitrogen, Carlsbad, Calif.) on their web site at the following URL: www.invit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Car

US Patent
LigandPNGBDBM285865(US10081606, Compound I-14 | US9765038, Compound I-...)
Affinity DataIC50: 650nMAssay Description:The mechanics of the assay platform are best described by the vendor (Invitrogen, Carlsbad, Calif.) on their web site at the following URL: www.invit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Car

US Patent
LigandPNGBDBM202374(US9238629, I-14 | US9238629, I-6 | US10081606, Com...)
Affinity DataIC50: 650nMAssay Description:The mechanics of the assay platform are best described by the vendor (Invitrogen, Carlsbad, Calif.) on their web site at the following URL: www.invit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Car

US Patent
LigandPNGBDBM202381(US9238629, I-13 | US10081606, Compound I-13 | US97...)
Affinity DataEC50: >1.00E+3nMAssay Description:The mechanics of the assay platform are best described by the vendor (Invitrogen, Carlsbad, Calif.) on their web site at the following URL: www.invit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Car

US Patent
LigandPNGBDBM202383(US9238629, I-15 | US10081606, Compound I-15 | US97...)
Affinity DataEC50: >1.00E+3nMAssay Description:The mechanics of the assay platform are best described by the vendor (Invitrogen, Carlsbad, Calif.) on their web site at the following URL: www.invit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Car

US Patent
LigandPNGBDBM202378(US9238629, I-10 | US10081606, Compound I-10 | US97...)
Affinity DataEC50: >1.00E+3nMAssay Description:The mechanics of the assay platform are best described by the vendor (Invitrogen, Carlsbad, Calif.) on their web site at the following URL: www.invit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Car

US Patent
LigandPNGBDBM202379(US9238629, I-11 | US10081606, Compound I-11 | US97...)
Affinity DataEC50: >1.00E+3nMAssay Description:The mechanics of the assay platform are best described by the vendor (Invitrogen, Carlsbad, Calif.) on their web site at the following URL: www.invit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Car

US Patent
LigandPNGBDBM202390(US9238629, I-22 | US10081606, Compound I-22 | US97...)
Affinity DataEC50: >1.00E+3nMAssay Description:The mechanics of the assay platform are best described by the vendor (Invitrogen, Carlsbad, Calif.) on their web site at the following URL: www.invit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2019
Entry Details
US Patent

Displayed 1 to 50 (of 62 total ) | Next | Last >>
Jump to: